← Open Payments lookup

CALI BRADBERRY: Open Payments

NPI 1831473198 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,672 in 178 payments from 17 companies in 2025. Trend: 2023 $1,628 · 2024 $1,746 · 2025 $2,672

Food & beverage: $2,561Education: $111
CompanyPaymentsAmount
ABBVIE INC.47$398
Otsuka America Pharmaceutical, Inc.26$333
Teva Pharmaceuticals USA, Inc.7$243
Vanda Pharmaceuticals Inc.13$228
E.R. Squibb & Sons, L.L.C.12$217
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$208
Neurocrine BioSciences, Inc.12$196
Axsome Therapeutics, Inc.10$167
Janssen Pharmaceuticals, Inc9$157
Takeda Pharmaceuticals U.S.A., Inc.7$152

Products named: VRAYLAR, REXULTI, FANAPT, COBENFY, CAPLYTA, INVEGA SUSTENNA, INGREZZA, Auvelity.

Industry payments across ID — which companies pay providers there.